Norfloxacin linked to adverse drug reaction skin hyperpigmentation, reveals IPC's Drug safety alert
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed that Norfloxacin which is widely used to treat certain bacterial infections, is linked with adverse drug reaction skin hyperpigmentation.This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India...
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed that Norfloxacin which is widely used to treat certain bacterial infections, is linked with adverse drug reaction skin hyperpigmentation.
This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.
For more details, check out the link given below:
Drug Safety Alert: IPC Flags Adverse Reactions Linked To Norfloxacin
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd